Depreciation, Depletion and Amortization of ImmunoGen, Inc. from 30 Jun 2010 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
ImmunoGen, Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 30 Jun 2010 to 31 Mar 2023.
  • ImmunoGen, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2023 was $448,000, a 5.3% decline year-over-year.
  • ImmunoGen, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1,783,000, a 12% decline from 2021.
  • ImmunoGen, Inc. annual Depreciation, Depletion and Amortization for 2021 was $2,017,000, a 4% decline from 2020.
  • ImmunoGen, Inc. annual Depreciation, Depletion and Amortization for 2020 was $2,101,000, a 48% decline from 2019.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

ImmunoGen, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $448,000 -$25,000 -5.3% 01 Jan 2023 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q1 2022 $473,000 -$78,000 -14% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q1 2021 $551,000 +$22,000 +4.2% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $529,000 -$671,000 -56% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $1,200,000 -$1,327,000 -53% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $2,527,000 +$1,021,000 +68% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $1,506,000 +$71,000 +4.9% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q3 2016 $1,528,000 +$401,000 +36% 01 Jul 2016 30 Sep 2016 10-Q 04 Nov 2016 2017 Q1
Q1 2016 $1,435,000 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q3 2015 $1,127,000 -$262,000 -19% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2017 Q1
Q3 2014 $1,389,000 +$227,000 +20% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015 2016 Q1
Q3 2013 $1,162,000 -$12,000 -1% 01 Jul 2013 30 Sep 2013 10-Q 30 Oct 2014 2015 Q1
Q3 2012 $1,174,000 +$11,000 +0.95% 01 Jul 2012 30 Sep 2012 10-Q 29 Oct 2013 2014 Q1
Q3 2011 $1,163,000 -$15,000 -1.3% 01 Jul 2011 30 Sep 2011 10-Q 31 Oct 2012 2013 Q1
Q3 2010 $1,178,000 01 Jul 2010 30 Sep 2010 10-Q 31 Oct 2011 2012 Q1

ImmunoGen, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,783,000 -$234,000 -12% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
2021 $2,017,000 -$84,000 -4% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 $2,101,000 -$1,927,000 -48% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $4,028,000 -$3,383,000 -46% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $7,411,000 +$1,448,000 +24% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $5,963,000 +$636,000 +12% 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2020 2019 FY
2016 $5,327,000 -$186,000 -3.4% 01 Jul 2015 30 Jun 2016 10-K 01 Mar 2019 2018 FY
2015 $5,513,000 +$915,000 +20% 01 Jul 2014 30 Jun 2015 10-K 07 Mar 2018 2017 FY
2014 $4,598,000 -$43,000 -0.93% 01 Jul 2013 30 Jun 2014 10-KT 03 Mar 2017 2016 FY
2013 $4,641,000 +$8,000 +0.17% 01 Jul 2012 30 Jun 2013 10-K 27 Aug 2015 2015 FY
2012 $4,633,000 -$304,000 -6.2% 01 Jul 2011 30 Jun 2012 10-K 28 Aug 2014 2014 FY
2011 $4,937,000 +$99,000 +2% 01 Jul 2010 30 Jun 2011 10-K 29 Aug 2013 2013 FY
2010 $4,838,000 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.